STO Equity Snapshot
BINV Weekly Equity Report
BioInvent International AB (publ)
What the company does
BioInvent International AB (publ), a clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally. The company's drug candidates include BI-1808, an anti- tumor necrosis factor receptor-2 (TNFR2) antibody in Phase 2a trial for the treatment of solid tumors and T-cell lymphoma; BI-1206, an anti-FcyRIIB antibody in Phase 1/2a trial for the treatment of non-Hodgkin's lymphoma, as well as Phase 1/2a trial to treat solid tumors; BI-1910, an anti-TNFR2 antibody in Phase 1/2a clinical trial to treat solid tumors; BI-1607, an anti-FcyRIIB antibody in Phase 1b/2a clinical …
What the weekly tape is saying
BINV closed the latest completed week at 24.20 SEK. The 4-week return is 5.2% and the 12-week return is 11.0%. Trend Signal is inactive, Market Dynamics is 1.36. Setup signature: Deep recovery attempt with a 42/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 26.22 SEK
- Vs Trend Line
- -7.7%
- Fair Value
- 28.18 SEK
- Vs Fair Value
- -14.1%
- 52W High
- 41.60 SEK
- 52W Low
- 19.22 SEK
- Drawdown
- -41.8%
- Range Position
- 22.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 10
- 52W Active Breadth
- 19.2%
- Sector Scope
- SE Healthcare
- Sector Rank
- 154 of 158
- Sector Percentile
- 2.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
SE Healthcare
- Tracked Peers
- 100
- 4W Rank
- 27 of 100
- Avg 1W
- 2.8%
- Avg 4W
- 1.2%
- Trend Breadth
- 29.0%
- Positive MD
- 69.0%
SE Biotechnology
- Tracked Peers
- 59
- 4W Rank
- 16 of 59
- Avg 1W
- 3.1%
- Avg 4W
- -1.6%
- Trend Breadth
- 30.5%
- Positive RS
- 22.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.36
- 4W MD Change
- 418.8%
- Relative Strength
- -25.20
- 4W RS Change
- 15.2%
- Expectation
- Undecided
- Probability
- 47.82%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.3M
- 13W Average
- 753.2K
- 52W Average
- 522.8K
- Vs 13W
- 1.7x
- Vs 52W
- 2.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 10.0%
- 52W Volatility
- 7.2%
- Upside Weeks
- 19
- Downside Weeks
- 33
- Downside Breadth
- 63.5%
- Avg Gain / Loss
- 6.2% / -4.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- STO
- Country
- SE
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- SEK
- Market Cap
- 2.2B
Opportunity signals
- Market Dynamics is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 24.20 SEK | -19.6% | 26.22 SEK | 28.18 SEK | 1.36 | -25.20 | 1.3M | Off |
| 5 Jun 2026 | 30.10 SEK | -9.1% | 26.42 SEK | 28.15 SEK | 1.29 | -8.24 | 816.6K | Off |
| 29 May 2026 | 33.10 SEK | 20.4% | 26.47 SEK | 28.08 SEK | 0.85 | -0.78 | 1.6M | Off |
| 22 May 2026 | 27.50 SEK | 19.6% | 26.43 SEK | 28.00 SEK | 0.15 | -18.32 | 1.1M | Off |
| 15 May 2026 | 23.00 SEK | -0.4% | 26.44 SEK | 27.99 SEK | -0.43 | -29.70 | 1.3M | Off |
| 8 May 2026 | 23.10 SEK | 5.2% | 26.57 SEK | 28.00 SEK | -0.76 | -30.83 | 479.8K | Off |
| 1 May 2026 | 21.95 SEK | -0.5% | 26.71 SEK | 28.03 SEK | -0.92 | -34.66 | 419.1K | Off |
| 24 Apr 2026 | 22.05 SEK | -1.3% | 26.91 SEK | 28.06 SEK | -0.93 | -35.94 | 464.8K | Off |
| 17 Apr 2026 | 22.35 SEK | -2.0% | 27.13 SEK | 28.11 SEK | -0.97 | -37.26 | 638.5K | Off |
| 10 Apr 2026 | 22.80 SEK | -0.9% | 27.41 SEK | 28.15 SEK | -1.09 | -35.04 | 334.6K | Off |
| 3 Apr 2026 | 23.00 SEK | 3.1% | 27.62 SEK | 28.19 SEK | -1.19 | -31.81 | 298.3K | Off |
| 27 Mar 2026 | 22.30 SEK | 2.3% | 27.81 SEK | 28.23 SEK | -1.17 | -31.98 | 537.4K | Off |
| 20 Mar 2026 | 21.80 SEK | -0.9% | 28.10 SEK | 28.28 SEK | -1.09 | -33.94 | 555.1K | Off |
| 13 Mar 2026 | 22.00 SEK | -3.1% | 28.63 SEK | 28.31 SEK | -0.95 | -37.20 | 306.7K | Off |